Lar Espana Real Estate SOCIMI, S.A., invests in and manages real estate assets, focusing on retail properties throughout Spain, office properties in Madrid & Barcelona, & with the possibility of investing opportunistically on residential assets.

LAR ESPANA RE SA ORD by LAR Espana Real Estate SA

Lar Espana Real Estate

<a href="https://www.bloomberg.com/news/articles/2021-07-27/medical-technology-firm-fluidigm-is-said-to-explore-sale" title="https://www.bloomberg.com/news/articles/2021-07-27/medical-technology-firm-fluidigm-is-said-to-explore-sale">https://www.bloomberg.com/news/articles/2021-07-27/medical-technology-firm-fluidigm-is-said-to-explore-sale</a>

News

Rumors

FLDM

Bloomberg Reported Tuesday, Fluidigm is Exploring a Sale

SVB Leerink analyst Stephanie Davis maintains Inovalon Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOV#NASDAQ">INOV</a>) with a Outperform and raises the price target from $35 to $45.

Price Target

Analyst Ratings

INOV

SVB Leerink Maintains Outperform on Inovalon Holdings, Raises Price Target to $45

Piper Sandler analyst Arvind Ramnani upgrades Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) from Neutral to Overweight and raises the price target from $221 to $280.

Upgrades

GLOB

Piper Sandler Upgrades Globant to Overweight, Raises Price Target to $280

SVB Leerink analyst Richard Newitter maintains Stryker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>) with a Outperform and raises the price target from $290 to $300.

SVB Leerink Maintains Outperform on Stryker, Raises Price Target to $300

DA Davidson analyst Linda Bolton Weiser maintains Mattel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) with a Buy and raises the price target from $28.5 to $32.

DA Davidson Maintains Buy on Mattel, Raises Price Target to $32

LG Electronics (LG) and Magna International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mga#NYSE">MGA</a>) today signed the transaction agreement which establishes a joint venture between the two companies. The new company, to be called LG Magna e-Powertrain, is headquartered in Incheon, South Korea and will be led by a strong management team.
Leading the new company will be CEO Cheong Won-suk, a 20-year LG veteran who was most recently vice president and head of the LG Vehicle component Solutions Company's Green Business. Prior to LG, Cheong spent nearly a decade with Daewoo Motors R&amp;D.
Javier Perez, who has been with Magna since 2016, will be the new company's COO. He will be responsible for overseeing the day-to-day operations of the joint venture. Perez brings nearly a quarter century of automotive manufacturing and quality control experience to LG Magna e-Powertrain, 18 of those years based in Asia.
The creation of the joint venture unifies Magna's strength in electric powertrain systems and world-class automotive manufacturing, with LG's expertise in component development for e-motors and inverters. Announcing LG Magna e-Powertrain's executive team marks a key milestone for the joint venture company, which will manufacture e-motors, inverters and on-board chargers and, for certain automakers, related e-drive systems.
The design, engineering and manufacturing synergies created by LG Magna e-Powertrain is expected to enable both companies to quickly react to market trends and capitalize on the growing global shift toward vehicle electrification. The new company will develop powertrain components that offer automakers a scalable portfolio, from complete solutions enabling electrification and functionality to integrating intelligent operating software and controls in new e-drive systems.
"Partnering with Magna enables LG to scale-up its global production, provide additional business opportunities and offer synergies in procurement and technological innovation," said CEO Cheong. "The integrated and collaborative approach is expected to deliver quickly for customers and capitalize on the rapid growth of the worldwide electric powertrain market."
"The market for e-motors, inverters and electric drive systems is expected to have significant growth between now and 2030. Our joint venture company brings together experts from Magna and LG to deliver a world-class portfolio of electric solutions," said COO Perez. "Leveraging existing technologies, engineering capabilities and global footprints, LG Magna e-Powertrain seeks to enable advancements that help automakers achieve some of the biggest challenges ahead in electrifying their full vehicle lineups."

LG and Magna Sign JV Agreement

<h3>Gainers</h3>
<ul>
<li>Intrusion Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intz#NASDAQ">INTZ</a>) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced the departure of its CEO.</li>
<li>Oragenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NASDAQ">OGEN</a>) shares jumped 34.1% to close at $0.8388 on Tuesday after the company announced it entered into a licensing agreement with the National Research Council of Canada that will enable it to pursue the rapid development of vaccines against SARS-CoV-2 and its variants.</li>
<li>SGOCO Group, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgoc#NASDAQ">SGOC</a>) rose 29.6% to settle at $11.00.</li>
<li>BiondVax Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bvxv#NASDAQ">BVXV</a>) surged 26.9% to close at $3.44. The company, last month, reported a narrower quarterly loss.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) rose 25.2% to settle at $5.51, rebounding after the Chinese education sector dipped on Monday following a policy from the Chinese government which may force for-profit education companies to become non-profit.</li>
<li>EyeGate Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eyeg#NASDAQ">EYEG</a>) shares gained 20.8% to close at $3.77 after the company said it has entered a non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic specialty pharmaceutical company focused on using light sensitive &quot;photoswitch&quot; small molecules, specifically designed to restore vision in patients with inherited and age-related degenerative retinal diseases. The company also announced that Brian Strem, co-founder and managing director of Bayon Therapeutics, was appointed as permanent president, CEO and board member, effective immediately.</li>
<li>IRSA Propiedades Comerciales SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ircp#NASDAQ">IRCP</a>) climbed 20.4% to settle at $3.01.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) gained 19.2% to close at $3.98.</li>
<li>NanoViricides, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nnvc#NYSE">NNVC</a>) rose 17.4% to settle at $4.92.</li>
<li>U.S. Physical Therapy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/usph#NYSE">USPH</a>) jumped 17.4% to settle at $119.50. U.S. Physical Therapy is expected to release Q2 earnings on August 5.</li>
<li>Gaotu Techedu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gotu#NYSE">GOTU</a>) gained 15.6% to close at $2.89.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) jumped 15.3% to close at $8.60 after reporting Q2 results.</li>
<li>Orbsat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osat#NASDAQ">OSAT</a>) climbed 15.1% to settle at $6.62. Orbsat recently announced its Global Telesat Communications unit has entered into an agreement with Alibaba.com. GTC will be a Gold-Supplier on the e-commerce website.</li>
<li>ObsEva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) shares gained 13.9% to close at $2.87. Organon &amp; Co. and ObsEva announced the companies have entered into an agreement whereby Organon will license the global development, manufacturing and commercial rights to ebopiprant, an investigational compound being evaluated as a potential treatment for preterm labor by reducing inflammation and uterine contractions.</li>
<li>Dyadic International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dyai#NASDAQ">DYAI</a>) rose 13.1% to close at $3.89 after the company reported technology transfer and licensing agreement with South Africa&#39;s Rubic Consortium aiming to &#39;develop and commercialize vaccines for distribution throughout the African continent.&#39;</li>
<li>Inovalon Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inov#NASDAQ">INOV</a>) surged 13% to close at $36.95. Nordic Capital is in advanced talks to acquire Inovalon Holdings Inc., Bloomberg reported.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) gained 12.5% to settle at $22.40. Morgan Stanley initiated coverage on Dingdong (Cayman) with an Overweight rating and announced a price target of $28.</li>
<li>Flora Growth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) rose 12.2% to close at $5.07. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to create a joint venture, through which it will handle registration, sales and distribution of KaLaya products in Colombia, Mexico and other Latin American countries.</li>
<li>Turning Point Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpb#NYSE">TPB</a>) climbed 10.5% to close at $51.73 after the company posted upbeat Q2 results and raised FY21 guidance.</li>
<li>Beyond Air, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xair#NASDAQ">XAIR</a>) climbed 10.4% to settle at $7.86.</li>
<li>Repligen Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgen#NASDAQ">RGEN</a>) rose 9.9% to close at $226.38 following quarterly results.</li>
<li>Eastside Distilling, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/east#NASDAQ">EAST</a>) gained 9.4% to close at $4.06.</li>
<li>APi Group Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/apg#NYSE">APG</a>) shares gained 9.4% to close at $22.26. Carrier agreed to sell its Chubb Fire &amp; Security Business to APi Group Corporation for an enterprise value of $3.1 billion.</li>
<li>The Aaron&#39;s Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aan#NYSE">AAN</a>) climbed 8.7% to settle at $30.13 after the company reported strong Q2 results and raised FY21 sales guidance.</li>
<li>TriNet Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnet#NASDAQ">TNET</a>) rose 7.8% to close at $78.91 following Q2 results.</li>
<li>Graphic Packaging Holding Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpk#NYSE">GPK</a>) surged 7.2% to settle at $18.75 following strong quarterly sales.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) gained 6.5% to close at $2.62 as the company reported strong SMB user growth with over 2x new sign-ups.</li>
<li>F5 Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffiv#NASDAQ">FFIV</a>) shares rose 6.2% to close at $204.57 after the company reported upbeat results for its third quarter. The company also said it sees Q4 adjusted earnings of $2.68 to $2.80 per share on sales of $660 million to $680 million.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) shares fell 45.4% to close at $15.75 on Tuesday. SkyWater Technology reported that it will invest $56 million in capacity expansion and gallium nitride technology.</li>
<li>Bit Digital, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btbt#NASDAQ">BTBT</a>) fell 33.6% to close at $5.89. Bit Digital shares jumped 110% on Monday after the company, and Digihost, announced they entered into a second strategic co-mining agreement.</li>
<li>Infinity Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infi#NASDAQ">INFI</a>) dipped 31.5% to settle at $1.52 after the company highlighted the presentation of updated data from Phase 2 MARIO-275 trial in urothelial cancer and Phase 2 MARIO-3 trial in triple negative breast cancer.</li>
<li>NanoVibronix Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naov#NASDAQ">NAOV</a>) fell 22.6% to close at $1.47. NanoVibronix recently said it shipped first order of PainShield Plus.</li>
<li>The9 Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncty#NASDAQ">NCTY</a>) dropped 22.2% to close at $10.42 after jumping over 54% on Monday.</li>
<li>Code Chain New Continent Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccnc#NASDAQ">CCNC</a>) dropped 19.5% to settle at $1.73 after surging 13% on Monday.</li>
<li>ATI Physical Therapy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atip#NYSE">ATIP</a>) fell 19.1% to settle at $3.82 after various analysts downgraded the stock.</li>
<li>Adagene Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adag#NASDAQ">ADAG</a>) dipped 18.7% to close at $13.70. Adagene recently entered into a clinical trial collaboration and supply agreement with Merck &amp; Co Inc.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) fell 18.6% to settle at $2.97 after the company reported launch of $25 million common stock offering.</li>
<li>GasLog Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glop#NYSE">GLOP</a>) fell 18.3% to settle at $4.30 after reporting downbeat quarterly results.</li>
<li>NXT-ID Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtd#NASDAQ">NXTD</a>) fell 17.6% to close at $0.7420 after surging 15% on Monday.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) fell 17% to close at $11.45. Faraday Future announced that all 300 of its invite-only FF 91 futurist alliance edition vehicles have been pre-ordered.</li>
<li>Boqii Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bq#NYSE">BQ</a>) dipped 16.9% to settle at $2.80 on continued weakness amid regulatory concerns regarding education and technology companies.</li>
<li>BlueCity Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blct#NASDAQ">BLCT</a>) dropped 16.7% to close at $5.14.</li>
<li>Takung Art Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tkat#NASDAQ">TKAT</a>) fell 16.7% to settle at $5.80.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclk#NASDAQ">ICLK</a>) fell 16.4% to close at $5.30.</li>
<li>Oramed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ormp#NASDAQ">ORMP</a>) dipped 16% to settle at $13.42. Oramed Pharmaceuticals recently announced several updates for its majority-owned company Oravax Medical Inc.</li>
<li>180 Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atnf#NASDAQ">ATNF</a>) dropped 15.8% to close at $7.08.</li>
<li>Waterdrop Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wdh#NYSE">WDH</a>) fell 15.4% to close at $4.28.</li>
<li>AiHuiShou International Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rere#NYSE">RERE</a>) fell 15.2% to close at $11.09.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) shares declined 14.9% to settle at $34.70 on continued weakness amid regulatory concerns regarding education and technology companies.</li>
<li>Peabody Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/btu#NYSE">BTU</a>) fell 14.7% to close at $10.26 amid a dip in crude futures.</li>
<li>Futu Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/futu#NASDAQ">FUTU</a>) fell 14.5% to close at $98.74 after declining around 7% on Monday.</li>
<li>Future Fintech Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) shares declined 13.9% to settle at $2.30 after climbing 10% on Monday.</li>
<li>Sos Ltd - ADR (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sos#NYSE">SOS</a>) fell 13.8% to close at $2.62 after climbing over 22% on Monday.</li>
<li>Smart Share Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/em#NASDAQ">EM</a>) dropped 13.7% to settle at $4.16.</li>
<li>Imv Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imv#NASDAQ">IMV</a>) fell 12.2% to close at $1.80 after surging over 25% on Monday. IMV recently announced it priced a 14,285,714 unit offering at $1.75 per unit.</li>
<li>Inozyme Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inzy#NASDAQ">INZY</a>) dipped 11.3% to settle at $17.03. Inozyme Pharma recently received orphan drug designation for INZ-701 from the European Medicines Agency for the treatment of ABCC6 deficiency.</li>
<li>Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>) fell 11% to close at $66.00.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) declined 10.8% to close at $4.69 after the company reported a wider quarterly loss.</li>
<li>Canaan Inc - ADR (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/can#NASDAQ">CAN</a>) shares declined 10.6% to close at $5.97 after surging 16% on Monday.</li>
<li>Kiromic Biopharma Inc(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krbp#NASDAQ">KRBP</a>) shares fell 8.6% to close at $2.86 after the company said it has completed the acquisition of InSilico Solutions.</li>
<li>Morphosys Ag (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) shares dropped 8% to settle at $13.66. MorphoSys shares fell 8% on Monday after the company announced it updated financial guidance for 2021.</li>
<li>Powerbridge Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbts#NASDAQ">PBTS</a>) fell 5.2% to settle at $1.29 after the company announced it will build a supply chain management SaaS platform based on blockchain technology.</li>
</ul>

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAG

ASAN

ATIP

ATNF

BLCT

BTBT

BVXV

CCNC

DYAI

EAST

EYEG

FFIE

FFIV

FLGC

FTFT

FUTU

GLOP

GSX Techedu Inc. American Depositary Shares

GOTU

ICLK

INFI

INTZ

INZY

IRCP

JZXN

KRBP

MEDS

MINM

Morgan Stanley Capital Protected Notes for S&P 500 Index

NAOV

NCTY

NNVC

NXTD

OBSV

OGEN

ORMP

OSAT

PBTS

RERE

RGEN

SGOC

SKYT

TKAT

TNET

USPH

XAIR

XELA

XPEV

62 Biggest Movers From Yesterday

SVB Leerink analyst Stephanie Davis maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Outperform and lowers the price target from $266 to $218.

TDOC

SVB Leerink Maintains Outperform on Teladoc Health, Lowers Price Target to $218

Jefferies analyst Anthony Petrone upgrades ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) from Underperform to Hold and raises the price target from $170 to $240.

Jefferies Upgrades ResMed to Hold, Raises Price Target to $240

Jefferies initiates coverage on Karuna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRTX#NASDAQ">KRTX</a>) with a Buy rating and announces Price Target of $158.

Initiation

KRTX

Jefferies Initiates Coverage On Karuna Therapeutics with Buy Rating, Announces Price Target of $158

Jefferies analyst Stephen Volkmann initiates coverage on Electric Last Mile Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELMS#NASDAQ">ELMS</a>) with a Buy rating and announces Price Target of $18.

ELMS

Jefferies Initiates Coverage On Electric Last Mile Solns with Buy Rating, Announces Price Target of $18

RBC Capital analyst Brad Erickson initiates coverage on Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) with a Sector Perform rating and announces Price Target of $17.

SKLZ

RBC Capital Initiates Coverage On Skillz with Sector Perform Rating, Announces Price Target of $17

Goldman Sachs downgrades Enagas (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ENGGY#OTC">ENGGY</a>) from Buy to Neutral.

Downgrades

ENGGY

Goldman Sachs Downgrades Enagas to Neutral

RBC Capital analyst Arun Viswanathan downgrades Atotech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATC#NYSE">ATC</a>) from Outperform to Sector Perform and lowers the price target from $27 to $26.

RBC Capital Downgrades Atotech to Sector Perform, Lowers Price Target to $26

Piper Sandler analyst Matthew Breese upgrades NBT Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTB#NASDAQ">NBTB</a>) from Neutral to Overweight and announces $40 price target.

NBTB

Piper Sandler Upgrades NBT Bancorp to Overweight, Announces $40 Price Target

Stifel analyst W. Andrew Carter initiates coverage on Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) with a Buy rating and announces Price Target of $220.

Stifel Initiates Coverage On Scotts Miracle Gro with Buy Rating, Announces Price Target of $220

Baird analyst Justin Kleber initiates coverage on Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) with a Outperform rating and announces Price Target of $105.

CHWY

Baird Initiates Coverage On Chewy with Outperform Rating, Announces Price Target of $105

Piper Sandler analyst Ian Macpherson downgrades Helix Energy Solutions Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) from Overweight to Neutral and lowers the price target from $5.3 to $4.5.

Piper Sandler Downgrades Helix Energy Solutions Gr to Neutral, Lowers Price Target to $4.5

Jefferies analyst Samad Samana downgrades Five9 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) from Buy to Hold and announces $200 price target.

FIVN

Jefferies Downgrades Five9 to Hold, Announces $200 Price Target

Morgan Stanley upgrades Sony Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) from Equal-Weight to Overweight.

Sony Group Corporation American Depositary Shares

Recent Quotes

Related Companies

Lar Espana Real Estate Frequently Asked Questions

How do I buy Lar Espana Real Estate (LAREF) stock?

Who are Lar Espana Real Estate's (LAREF) competitors?

What is the target price for Lar Espana Real Estate (LAREF) stock?

Current Stock Price for Lar Espana Real Estate (LAREF)?

Does Lar Espana Real Estate (LAREF) pay a dividend?

When is Lar Espana Real Estate (OTC:LAREF) reporting earnings?

Is Lar Espana Real Estate (LAREF) going to split?

What sector and industry does Lar Espana Real Estate (LAREF) operate in?